Key Drivers
- Margin Recovery
- High Leverage
- Limited Coverage
AIAI Summary
Celanese is a leveraged earnings-normalization trade, not a simple cyclical bargain: investors should wait for several quarters of durable EBITDA and free-cash-flow conversion to validate deleveraging, as Q3's expected EPS step-down and ~1.7x interest coverage leave equity highly exposed to another demand or margin downturn.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Recovery
- •High Leverage
- •Limited Coverage
CE's profitability rebounded sharply in Q2 2026, but high leverage, thin interest coverage, and weaker cash-flow scale warrant caution despite improved valuation.
Price Behavior
Key Price Behavior Insights:
- •Failed rebound
- •Weak momentum
- •Range-bound risk
CE is cautiously negative over the last month, with weakening momentum and a reversal from $47.22; watch $44.10–$44.70 support for a breakdown or $46.80–$47.20 for renewed upside.
Rebounded from $44.13 to $47.22 before reversing to $45.41
Sentiment & News
Key News Insights:
- •Institutional Accumulation
- •Insider Buying
- •Debt Reduction
Celanese's institutional buying, insider purchase, and Nutrinova stake sale to reduce debt signal improving investor confidence and a potentially supportive outlook.
The combined capital inflows and deleveraging initiative could support Celanese shares, though analyst sentiment remains unspecified
Similar Companies in Basic Materials
Other companies in the same sector with AI ratings